Viewing Study NCT00357656


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-07-14 @ 1:24 PM
Study NCT ID: NCT00357656
Status: COMPLETED
Last Update Posted: 2021-05-19
First Post: 2006-07-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
Sponsor: Baxalta now part of Shire
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hemophilia A (severe or moderately severe) View